微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 85.18% | -9.42% | -5.46% | 11/56 | 48.4% | 我武生物 | 95.38% | 行业排名> |
| 2026-06-30 | 90.1% | 8.23% | 3.74% | 7/56 | 53.56% | 荣昌生物 | 95.71% | 行业排名> |
| 2026-03-31 | 86.85% | 4.74% | -6.63% | 10/56 | 60.48% | 我武生物 | 95.25% | 行业排名> |
| 2025-12-31 | 93.02% | 12.95% | -1.09% | 3/56 | 64.39% | 我武生物 | 95.24% | 行业排名> |
| 2025-09-30 | 94.05% | 16.65% | 12.97% | 2/56 | 66.48% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 83.25% | 27% | 0.39% | 14/56 | 67.83% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 82.93% | 26.51% | 0.69% | 15/56 | 36.56% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 82.36% | 111.52% | 2.15% | 12/56 | 67.21% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 80.62% | 194.6% | 23% | 15/56 | 69.22% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 65.55% | 156.58% | 0% | 34/56 | 68.29% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 65.55% | 2% | 68.36% | 35/56 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 38.94% | 442.5% | 42.27% | 43/56 | 67.71% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 27.37% | 2% | 7.12% | 44/56 | 67.65% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 25.55% | 314.48% | 324.73% | 45/56 | 62.76% | 华兰疫苗 | 101.02% | 行业排名> |
| 2022-12-31 | -11.37% | -122.52% | 4.56% | 50/56 | 19.27% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-06-30 | -11.91% | 2% | -123.59% | 49/56 | 68.78% | 我武生物 | 95.39% | 行业排名> |
| 2021-12-31 | 50.49% | 2% | 2% | 39/56 | 71.82% | 我武生物 | 95.63% | 行业排名> |